Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Clinical Calcium|October 30, 2012
[The regulatory mechanisms of bone metabolism by semaphorin]Mikihito Hayashi, Tomoki Nakashima, Hiroshi Takayanagi
Clinical Calcium|May 3, 2012
[Regulation of bone resorption by osteocytes]Tomoki Nakashima, Mikihito Hayash, Hiroshi Takayanagi
Current Opinion in Rheumatology|April 23, 2003
RANKL and RANK as novel therapeutic targets for arthritisTomoki Nakashima, Teiji Wada, Josef M Penninger
Bone|September 4, 2012
Osteocyte control of osteoclastogenesisCharles A O'Brien, Tomoki Nakashima, Hiroshi Takayanagi
Endocrinology|August 5, 2022
Osteoblast Lineage Cell-derived Sema3A Regulates Bone Homeostasis Independently of AndrogensYu Yamashita, Mikihito Hayashi, Mitsuru Saito, et al.
Trends in Molecular Medicine|December 17, 2005
RANKL-RANK signaling in osteoclastogenesis and bone diseaseTeiji Wada, Tomoki Nakashima, Nishina Hiroshi, et al.
Immunity|June 19, 2016
Sepsis-Induced Osteoblast Ablation Causes ImmunodeficiencyAsuka Terashima, Kazuo Okamoto, Tomoki Nakashima, et al.
Biochemical and Biophysical Research Communications|November 12, 2019
Mechanotransduction via the Piezo1-Akt pathway underlies Sost suppression in osteocytesFumiyuki Sasaki, Mikihito Hayashi, Yuki Mouri, et al.
Arthritis and Rheumatism|April 11, 2003
Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblastsHiroyuki Murota, Youichiro Hamasaki, Tomoki Nakashima, et al.
Nature|April 24, 2012
Osteoprotection by semaphorin 3AMikihito Hayashi, Tomoki Nakashima, Masahiko Taniguchi, et al.
Pageof 9